Content area

|
|

SSRI og graviditet

SSRI overføres via maters serum til den føtale cirkulation.
Forfatter(e)
Tahmineh Hassanzadeh1, Lars Henning Pedersen2 & Poul Videbech1 1) Afdeling Q – Afdeling for Depression og Angst, Aarhus Universitetshospital 2) Gynækologisk-obstetrisk Afdeling Y, Institut for Klinisk Medicin, Aarhus Universitetshospital Ugeskr Læger 2014;176:V09130567
Reference: 
Ugeskr Læger 2014;176:V09130567
Blad nummer: 
Sidetal: 
236-239
Selective serotonin reuptake inhibitors and pregnancy
Selective serotonin reuptake inhibitors (SSRI) is the most common pharmacological treatment for depression during pregnancy. In recent years it has been under suspicion of causing spontaneous abortion, cardiac malformation, preterm birth, low birthweight, persistent pulmonary hypertension and neonatal withdrawal syndrome in the newborn exposed to SSRI. But the risks of SSRI side effects are low compared to background population. Non-pharmacological treatment methods should also be considered while treating pregnant women with depression. This paper describes the present state of knowledge about the potential complications associated with the use of SSRI during pregnancy and points at treatment recommendations to the physician.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Niels Rud Haagensen | 25/09
10 kommentarer
af John Vitger | 25/09
3 kommentarer
af Simon Bahn Glerup | 24/09
7 kommentarer
af Peter Matzen | 21/09
1 Kommentar
af Finn Vallø Hansen | 21/09
1 Kommentar
af Johan Ludvig Reventlow | 19/09
2 kommentarer
af Andreas Gothardt Lundh | 17/09
1 Kommentar
af Bjørn Søeberg | 17/09
33 kommentarer